John Doux, M.D.
DirectoratPalvella Therapeutics· In the 2025 proxy
John Doux, M.D. sits on 3 public boards.
Experience
- Palvella TherapeuticsPublic company · 1 yr
- Director2025 – Present · 1 yrStock in role +1,150%
- Ceptaris Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Legacy PalvellaPublic company · 3 yr
- Director2019 – 2022 · 3 yrNo stock prices for these years
- Dermatology SummitPublic company · 8 yr
- Director2013 – 2021 · 8 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?